Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
- 4 November 2020
- journal article
- editorial
- Published by Elsevier BV in The Lancet
- Vol. 396 (10263), 1614-1616
- https://doi.org/10.1016/s0140-6736(20)32318-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack RateJournal of Clinical Microbiology, 2020
- SARS-CoV-2 vaccines in developmentNature, 2020
- Long-term consequences of COVID-19: research needsThe Lancet Infectious Diseases, 2020
- A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2Science, 2020
- Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic periodScience, 2020
- Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal KenyaThe Journal of Infectious Diseases, 2018
- Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration PatientsThe Journal of Infectious Diseases, 2018
- Implications of vaccination and waning immunityProceedings. Biological sciences, 2009
- Spatial heterogeneity and the design of immunization programsMathematical Biosciences, 1984